Skip to main content
Clinical Trials/NCT01109303
NCT01109303CompletedNot Applicable

Prospective Randomized Multicentric Trial Comparing a Static Implant and a Dynamic Implant in the Surgical Treatment of Ankle Syndesmosis Rupture

Hopital de l'Enfant-Jesus2 sites in 1 country70 target enrollmentStarted: October 1, 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
70
Locations
2
Primary Endpoint
Olerud-Molander score

Study Overview

Brief Summary

Ankle fracture is frequent and its number is increasing. In Canada, surgical treatment of these lesions is advised and the options currently used all have in common a rigid fixation of the syndesmosis which results in residual stiffness and a high level of secondary surgery, mostly to remove the implant.

The purpose of the study is to compare the treatment of ankle syndesmotic rupture by a dynamic fixation to a static fixation suggesting that the dynamic fixation method will improve the Olerud-Molander functional score of more than 15 points at the 3 months follow-up.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • men or women ≥ 18 years-old;
  • ankle fracture type 44-C (AO classification) with an AP, lateral and mortise X-ray views of the ankle and an AP and lateral X-ray views of the leg;
  • open fractures (Gustilo I-IIIb) or closed;
  • trauma-surgery delay of less than 7 days;
  • consent form signed.

Exclusion Criteria

  • ankle fractures without syndesmotic lesion;
  • fracture associated with neuro-vascular lesions (Gustillo IIIc);
  • pathologic fracture;
  • fracture in a polytraumatized patient;
  • fracture of a bone in the ipsilateral leg;
  • men or women > 65 years-old;
  • chronic cardiac insufficiency (ejection fraction < 30%);
  • lower leg chronic venous insufficiency;
  • neuro-arthropathic foot (Charcot, diabetes, etc...);
  • body mass index ≥ 40;
  • past medical history of fracture of the same ankle;
  • medical conditions too serious for a surgery;
  • men or women unfit to consent;
  • any other conditions that make the examinator thinks that the follow up would be problematic.

Outcomes

Primary Outcomes

Olerud-Molander score

Time Frame: 3 months after surgery

The Olerud-Molander scoring scale was chosen because it adequately represents the ankle performance following surgery (trauma or elective basis). It comprises nine functional parameters which are concerned with primary complaints, the ability to perform simple tasks and the everyday life activities.

Secondary Outcomes

  • Rate of secondary surgery(within one year following surgery)
  • Radiological loss of reduction(12 months after surgery)
  • Implant failure(one year after surgery)
  • American Orthopaedic Foot and Ankle Society (AOFAS) score of hindfoot(12 weeks after surgery)
  • AOFAS score of hindfoot(12 months after surgery)
  • Return to professional activities(3 months after surgery)
  • Pain on visual analog scale (VAS)(12 weeks after surgery)
  • Pain on VAS(12 months after surgery)
  • Range of motion(12 months after surgery)
  • Muscular trophicity measure of the leg(12 months after surgery)
  • Ankle circumference measure(12 months after surgery)

Investigators

Sponsor
Hopital de l'Enfant-Jesus
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Pelet Stephane

Dr Stephane Pelet MD, PhD Orthopedic surgeon

Hopital de l'Enfant-Jesus

Study Sites (2)

Loading locations...

Similar Trials